IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas

Published 2010 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
Authors
Keywords
-
Journal
NEUROLOGY
Volume 75, Issue 17, Pages 1560-1566
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-10-26
DOI
10.1212/wnl.0b013e3181f96282

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.